Will Sleeping Sickness Be COMPLETELY Eliminated By 2030?

Join us on a global health mission to eliminate sleeping sickness, a neglected tropical disease transmitted by the tsetse fly. Learn how Sanofi is working to combat this disease and improve public health worldwide. takeaways Sleeping sickness is a curable disease that affects remote communities. Neglected tropical diseases often receive limited funding and attention. Sanofi is committed to eliminating sleeping sickness by 2030. Collaboration with WHO and DNDi is crucial for success. Fexinidazole is a significant advancement in treating sleeping sickness. Accurate diagnostics are essential for effective treatment. The fight against neglected diseases benefits global health. Eliminating sleeping sickness could set a precedent for other diseases. Community healthcare workers play a vital role in treatment access. The private sector has an evolving role in global health initiatives. Chapters 00:00 The Story of Olivier and Sleeping Sickness 04:04 Understanding Neglected Tropical Diseases 12:02 Sanofi's Commitment to Sleeping Sickness 20:13 Milestones in Treating Sleeping Sickness 23:33 The Progression and Diagnosis of Sleeping Sickness 27:56 The Importance of Timely Diagnosis 28:51 Collaboration for Impact 31:02 Eliminating Sleeping Sickness by 2030 32:52 Advancements in Diagnostics 35:26 Challenges in Disease Elimination 36:41 The Role of Local Healthcare Workers 38:49 The Evolving Role of the Private Sector 41:26 Personal Rewards in Global Health 46:27 Inspiring Patient Stories 49:03 Advice for Young Professionals 50:26 Call for Expertise in Diagnostics 52:33 Collective Action for Global Health